Hodgkin's disease: controversies and challenges for the future

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Bleomycin / administration & dosage
• Bleomycin / adverse effects
• Bone Marrow Transplantation
• Combined Modality Therapy
• Dacarbazine / administration & dosage
• Dacarbazine / adverse effects
• Doxorubicin / administration & dosage
• Doxorubicin / adverse effects
• Drug Resistance
• Follow-Up Studies
• Hodgkin Disease / drug therapy
• Hodgkin Disease / mortality
• Hodgkin Disease / surgery
• Hodgkin Disease / therapy*
• Humans
• Immunocompromised Host
• Incidence
• Mechlorethamine / administration & dosage
• Mechlorethamine / adverse effects
• Neoplasms / chemically induced
• Neoplasms / epidemiology
• Neoplasms, Multiple Primary
• Neoplasms, Radiation-Induced / epidemiology
• Neoplasms, Radiation-Induced / etiology
• Prednisone / administration & dosage
• Prednisone / adverse effects
• Procarbazine / administration & dosage
• Procarbazine / adverse effects
• Radiotherapy / adverse effects
• Remission Induction
• Salvage Therapy
• Splenectomy / adverse effects
• Survival Analysis
• Survival Rate
• Time Factors
• Transplantation, Autologous
• Treatment Outcome
• Vinblastine
• Vincristine / administration & dosage
• Vincristine / adverse effects